Andere Sprachen Fusion Antibodies plc

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:14 04.06.2024			% 5 Tage	% 1. Jan.
3,45 ^GBX	-1,43 %		-6,76 %	-18,82 %

23.05.	Celadon liefert in die USA; Oxford BioDynamics-Goodbody-Pakt	AN
23.05.	Fusion Antibodies plc kündigt neuen Vertrag mit bestehendem Kundenprojekt zur Entwicklung eines Therapeutikums an	CI

Celadon ships to US; Oxford BioDynamics-Goodbody pact	23.05.
Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic	23.05.
Fusion Antibodies reports second-half rebound as new commercial strategy pays off	09.05.
EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	30.04.
Fusion Antibodies inks commercial contract for OptiPhage library	15.04.
Fusion Antibodies Secures Contract to Set Up OptiPhage Library	15.04.
Fusion Antibodies plc Enters into Commercial Contract to Develop a Bespoke OptiPhageTM Library	15.04.
Sondrel wins USD23 million contract	27.02.
Fusion Antibodies Lands Antibodies Contract with Diagnostics Company	27.02.
Fusion Antibodies plc Receives First Purchase Order Under the Master Services Agreement	27.02.
Fusion Antibodies raises GBP1.4 million via placing	14.02.
Fusion Antibodies Raises GBP1 Million via Share Issue	14.02.
Fusion Antibodies strikes follow-on research and development project	06.02.
Fusion Antibodies Receives Follow-On Project from US Biotechnology Client	06.02.
AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations	06.02.
Fusion Antibodies plc Receives Follow-On Project Award and R&D Update	06.02.
Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform	01.02.
Fusion Antibodies Receives R&D Tax Credit from UK Government	01.02.
FTSE 100 slips as miners hold down index	04.12.
Fusion Antibodies shares fall with revenue despite "positive" outlook	04.12.

Keine Ergebnisse zu dieser Suche